Expressive Helping for Chinese-Speaking Cancer Patients and Survivors
Feasibility of Expressive Helping for Chinese-Speaking Cancer Patients and Survivors
1 other identifier
interventional
60
1 country
1
Brief Summary
This study examines the feasibility, cultural-sensitivity, and health effects of the expressive helping intervention by conducting a single-arm trial with Chinese-speaking cancer patients and survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 7, 2019
CompletedFirst Posted
Study publicly available on registry
May 10, 2019
CompletedStudy Start
First participant enrolled
May 20, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2020
CompletedDecember 3, 2025
March 1, 2021
1.6 years
May 7, 2019
November 25, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Number of participants screened
The number of participants screened for eligibility will be counted.
through study completion, an average of 1 year
Compliance rate
Compliance rate is calculated by dividing the number of writing/voice-recording sessions finished by the number of sessions assigned.
through study completion, an average of 1 year
Retention rate
Retention rate is calculated by dividing the number of participants who began the study by the number of participants who finished the entire study.
through study completion, an average of 1 year
Meaningfulness of the study
We will ask participants open-ended questions about whether they felt participating in this study was meaningful to them.
This will be assessed approximately four weeks after the baseline
Secondary Outcomes (2)
Change in quality of life as assessed by the Functional Assessment of Cancer Therapy Scale (FACT).
Baseline; 1-month follow-up; 3-month follow-up
Change in depressive symptoms as assessed by the Center for Epidemiologic Studies Depression Scale (CES-D).
Baseline; 1-month follow-up; 3-month follow-up
Study Arms (1)
Expressive Helping
EXPERIMENTALParticipants complete four 20-minute writing/voice-recording sessions spaced one week apart. During the first week, the instructions will explain that cancer patients and survivors benefit from learning about other cancer survivors' experiences. They are told that the first three weeks of writing/voice-recording (writing/talking about their stress and coping at Week 1, deepest emotions about cancer at Week 2, self-affirmation and benefit finding at Week 3) are exercises designed to help them think about their cancer experiences and to prepare them to write/record the narrative they would share on Week 4. During Week 4, they are asked to write/record a narrative as if they are speaking to another Chinese person with cancer, adding advice and encouragements, and reminded that their writing/recording would be shared with other Chinese American cancer patients and survivors.
Interventions
Expressive helping harnesses the benefits of helping others (e.g., support giving) through writing or voice-recording. Expressive helping integrates two distinct areas of research showing that writing or speaking about ones' negative experiences and engaging in support giving behaviors can improve psychological well-being.
Eligibility Criteria
You may qualify if:
- Diagnosis of cancer (any type)
- Of Chinese descent
- Over the age of 18
- Can speaking and read Mandarin Chinese
You may not qualify if:
- Completed primary cancer treatment more than five years ago
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New York University
New York, New York, 10003, United States
MeSH Terms
Conditions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 7, 2019
First Posted
May 10, 2019
Study Start
May 20, 2019
Primary Completion
December 30, 2020
Study Completion
December 30, 2020
Last Updated
December 3, 2025
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share